AI Bias Analysis
4 models · Takes ~15 seconds
GSK agreed to buy Nuvalent, a cancer drug developer, in a deal worth $10.6 billion, as the company continues its expansion in oncology
Source
Stat News
Opens original article in a new tab
The Trump administration has warned more than 500 hospitals that they are failing to provide the public with basic pricing information.
AstraZeneca's GLP-1 pill, GSK's $10.6B cancer startup acquisition, and more biotech news from The Readout
(MedPage Today) -- A study commissioned by President Joe Biden's administration to investigate alcohol-related health harms was released independently on Tuesday, after President Donald Trump's administration decided not to feature the researchers...
The NIH has appointed researcher John Powers III to lead its infectious disease institute on an acting basis, after weeks of being in leadership limbo.
